Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Onakpoya, I, Heneghan, C, Aronson, J
פורמט:	Journal article
שפה:	English
יצא לאור:	BioMed Central 2016

פריטים דומים

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
מאת: Onakpoya, I, et al.
יצא לאור: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
מאת: Onakpoya, IJ, et al.
יצא לאור: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
מאת: Onakpoya, I, et al.
יצא לאור: (2016)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
מאת: Igho J. Onakpoya, et al.
יצא לאור: (2019-03-01)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
מאת: Onakpoya, I, et al.
יצא לאור: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
מאת: Onakpoya, I
יצא לאור: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
מאת: Onakpoya, I, et al.
יצא לאור: (2017)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
מאת: Daniele Sartori, et al.
יצא לאור: (2020-08-01)

Pharmacogenetics and adverse drug reactions
מאת: Ferner, R, et al.
יצא לאור: (2010)

An agenda for research on adverse drug reactions.
מאת: Aronson, J
יצא לאור: (2007)

Adverse drug reactions--no farewell to harms.
מאת: Aronson, J
יצא לאור: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
מאת: Aronson, J
יצא לאור: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
מאת: Edwards, I, et al.
יצא לאור: (2000)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
מאת: Aronson, J
יצא לאור: (2017)

Adverse drug reactions: keeping up to date.
מאת: Aronson, J, et al.
יצא לאור: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
מאת: Aronson, J
יצא לאור: (2013)

Paradoxical reactions: Under-recognized adverse effects of drugs?
מאת: Hauben, M, et al.
יצא לאור: (2006)

National differences in publishing papers on adverse drug reactions.
מאת: Ferner, R, et al.
יצא לאור: (2005)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
מאת: Onakpoya, IJ, et al.
יצא לאור: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
מאת: Aronson, Jeffrey K.
יצא לאור: (2006)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
מאת: Onakpoya, I, et al.
יצא לאור: (2018)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
מאת: Aronson, J
יצא לאור: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
מאת: Talbot, J, et al.
יצא לאור: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
מאת: Talbot, J, et al.
יצא לאור: (2012)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
מאת: Łukasz Dobrek
יצא לאור: (2022-08-01)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
מאת: James D. Noyes, et al.
יצא לאור: (2021-08-01)

Joining the DoTS: new approach to classifying adverse drug reactions.
מאת: Aronson, J, et al.
יצא לאור: (2003)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
מאת: Smith, C, et al.
יצא לאור: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
מאת: Aronson, J
יצא לאור: (2005)

Lorcaserin in obesity: minimal benefits and ill-defined harms
מאת: Onakpoya, I, et al.
יצא לאור: (2019)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
מאת: Loke, Y, et al.
יצא לאור: (2006)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
מאת: Chun-Bing Chen
יצא לאור: (2023-01-01)

Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
מאת: Ann M. Moyer, et al.
יצא לאור: (2019-12-01)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
מאת: Aronson, J, et al.
יצא לאור: (2010)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
מאת: Talbot, J. C. C., et al.
יצא לאור: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
מאת: McDowell, SE, et al.
יצא לאור: (2013)

GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
מאת: Ziqi Zhang, et al.
יצא לאור: (2023-07-01)

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
מאת: Ruoqi Liu, et al.
יצא לאור: (2019-12-01)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
מאת: Derry, S, et al.
יצא לאור: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
מאת: Derry, S, et al.
יצא לאור: (2001)